Media Releases
2023
06/06/2023
New Kidney Research UK Report Shows Kidney Disease is a Public Health Emergency
21/05/2023
Heartbreaking impact of endometriosis on women laid bare – The West Australian
18/05/2023
Video Interview – Exclusive Agreement with Sonic Healthcare USA
10/05/2023
Proteomics International & Sonic Healthcare USA sign exclusive licence agreement
10/05/2023
Proteomics seals exclusive deal for kidney test in US – The West Australian
10/05/2023
Proteomics International (ASX:PIQ) inks exclusive licence agreement to bring PromarkerD to the US market – The Market Herald
10/05/2023
Proteomics’ PromarkerD test enters the lucrative US market – THE SENTIMENT
05/05/2023
New diagnostic blood test showcased at world’s premier endometriosis conference
03/05/2023
PromarkerD test scores show treatment with canagliflozin can lessen risk of diabetic kidney disease
26/04/2023
Clinical Advisory Board expanded to support PromarkerD USA and global rollout
26/04/2023
Proteomics boosts kidney test prospects with board gains – The West Australian
31/03/2023
Endometriosis Awareness Month: What women need to watch out for – THE CAROUSEL
24/03/2023
New blood test for Endometriosis offers improved early screening
24/03/2023
Proteomics reveals new blood test to identify endometriosis – The West Australian
17/03/2023
PromarkerD Application for Australian Medicare Benefits Schedule Listing & Investor Webinar
Newsroom
News Archive
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
1
…
4
5
6
7
8
9
10
…
27
Subscribe
Subscripe to:
All Company news and updates
PromarkerD updates
PromarkerEso updates
PromakerEndo updates
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Name
This field is for validation purposes and should be left unchanged.
VISIT OUR NEW WEBSITE
Investor Relations
ASX Announcements
Share Price and Analyst Coverage
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting